Zhuochao Zhang Gaofei Wang Lei Du Jie Zhao Lichao Pan Gong Zhang Fei Wang Rong Liu
10.3389/fimmu.2023.1124482
Front Immunol
2023 May 24;14:1124482.
fgfr inhibitors advanced intrahepatic cholangiocarcinoma combined therapy immune checkpoint inhibitor pemigatinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/37292215/
Bile Duct Neoplasms / drug therapy Bile Duct Neoplasms / pathology Cholangiocarcinoma / genetics
Bile Duct Neoplasms / drug therapy Bile Duct Neoplasms / pathology Cholangiocarcinoma / genetics Case Reports Research Support, Non-U.S. Gov't Adult Bile Ducts, Intrahepatic / pathology Female Humans Immune Checkpoint Inhibitors / therapeutic use pemigatinib Immune Checkpoint Inhibitors
PMC10245386
37292215
Case Report: Persistent response to combination therapy of pemigatinib, chemotherapy, and immune checkpoint inhibitor in a patient with advanced intrahepatic cholangiocarcinoma
2023